KD-FLU Phase II Study in healthy Adults clinical trial

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222365

Enrollment

Registered

2014-01-16

Start date

2014-01-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza prevention

Interventions

investigational material(s) Generic name etc : KD-FLU INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Subcutaneousl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Subjects who are healthy adults aged between 20 inclusive and 65 exclusive at the time of obtaining informed consent. (2) Subjects who are able to give written informed consent.

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026